UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Qualification
Date Qualified:
December 10, 2024 9:30 A.M.
Form:
1-A
CIK:
0001589150
Company Name:
Regen BioPharma Inc
File Number:
024-12505